ACM
ELV icon

Argentus Capital Management’s Elevance Health ELV Stock Holding History

Argentus Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,759
Closed -$245K – 624
2015
Q4 		$245K Sell
1,759
-848
-33% -$117K 0.08% 236
2015
Q3 		$365K Buy
+2,607
New +$392K 0.05% 289

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Argentus Capital Management's ELV Position: Q1 2016 in Review

Argentus Capital Management sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 1,759 shares — an estimated $245K sold.

Argentus Capital Management first reported a position in ELV in Q3 2015 and held it in 2 quarters. The position peaked at $365K in Q3 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • Argentus Capital Management reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
  • Argentus Capital Management sold 1,759 Elevance Health shares in Q1 2016, an estimated $245K.
  • Argentus Capital Management first reported a position in Elevance Health in Q3 2015 and held it in 2 quarters.
  • Argentus Capital Management's Elevance Health position peaked at $365K in Q3 2015.
  • 770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Argentus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.